• Poster

Budget Impact of Adding Delayed-Release Dimethyl Fumarate to the Formulary for the Treatment of Relapsing Forms of Multiple Sclerosis

Citation

Mauskopf, J., Fay, M., Iyer, R., & Livingston, T. (2014, June). Budget Impact of Adding Delayed-Release Dimethyl Fumarate to the Formulary for the Treatment of Relapsing Forms of Multiple Sclerosis. Presented at ISPOR 19th Annual International Meeting, .

Abstract